The goal of this proposal is to improve the efficacy of adrenoviral liver directed gene therapy in the Gunn rat animal model of congenital non- hemolytic unconjugated hyperbilirubinemia. Crigler-Najjar syndrome type I, familial non-hemolytic jaundice and kernicterus, is a fatal disease which can potentially be cured by genetic complementation. The disease results from a genetic defect in the enzyme responsible for glucuronidation of bilirubin. In its severest form, bilirubin accumulates in the serum leading to kernicterus and death. One feature of this disease which makes it an ideal candidate for liver directed gene therapy is that no effective conventional therapy exists for Crigler- Najjar syndrome type I short of liver transplantation. Adenovirus vector mediated gene transfer of a human bilirubin glucuronsyltransferase cDNA (HUG Br 1) is able to transiently reverse the hyperbilirubinemia in Gunn rats. Two general approaches will be used to increase vector efficacy 1) engineer vectors to be less immunogenic and 2) combine vector delivery with pharmacologic immunosuppression. This proposal includes several novel interventions designed to augment expression of the transgene leading to increased efficacy of in vivo adenovirus gene therapy. The experimental design employs multiple modalities to detect gene transfer so that a drop in serum bilirubin may be correlated with other, more specific measures of gene transfer. The results obtained in this model should prove valuable to the development of liver directed gene therapy for other genetic and acquired diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08DK002438-03
Application #
2733816
Study Section
Special Emphasis Panel (SRC)
Program Officer
Podskalny, Judith M
Project Start
1996-08-19
Project End
2001-06-30
Budget Start
1998-09-20
Budget End
1999-06-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Askari, Fred K; Greenson, Joel; Dick, Robert D et al. (2003) Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. J Lab Clin Med 142:385-90
Kometiani, P; Askari, A; Liu, J et al. (2001) Downregulation of cardiac myocyte Na(+)-K(+)-ATPase by adenovirus-mediated expression of an alpha-subunit fragment. Am J Physiol Heart Circ Physiol 280:H1415-21
McDonnell, W M; Askari, F K (1997) Immunization. JAMA 278:2000-7